Trusted by both payers and providers, Moxe’s EHR-agnostic framework sets the new industry standard for clinical data exchange. MADISON, Wis.–(BUSINESS WIRE)–MoxeTrusted by both payers and providers, Moxe’s EHR-agnostic framework sets the new industry standard for clinical data exchange. MADISON, Wis.–(BUSINESS WIRE)–Moxe

Moxe Named Best in KLAS for Payer-Provider Data Exchange

3 min read

Trusted by both payers and providers, Moxe’s EHR-agnostic framework sets the new industry standard for clinical data exchange.

MADISON, Wis.–(BUSINESS WIRE)–Moxe Health, the leading EHR-agnostic partner for clinical data exchange, has been awarded the inaugural 2026 Best in KLAS award for Payer-Provider Data Exchange by KLAS Research. This recognition validates Moxe’s commitment to building a trusted, interoperable solution that serves the unique needs of both health plans and health systems.

“This award is a reflection of the trust our partners place in us,” said Dan Wilson, Founder of Moxe Health. “Since the inception of our business, we’ve worked to build a network that is rooted in trust and backed by clinical expertise. Our mission is to not just move data—but to move the industry forward. Being named Best in KLAS proves that our EHR-agnostic approach is the standard for secure, accurate, and scalable exchange.”

The Payer-Provider Data Exchange category evaluates vendors on their ability to improve collaboration and reduce administrative friction. Moxe’s top ranking highlights its excellence in:

  • Neutrality: A truly EHR-agnostic platform.
  • Accuracy: Delivering clinical data that both sides can trust.
  • Efficiency: Automating workflows to save time and reduce costs.

“The Best in KLAS winners have earned the trust of their customers over the past year. With this recognition, they set the standard for excellence through partnership in healthcare technology and services in the months to come,” shared Adam Gale, CEO, KLAS Research.

To determine this year’s winners, KLAS conducted surveys and evaluated vendors based on culture, loyalty, operations, product, relationship, and value. Among the reasons customers agreed Moxe was Best in KLAS was that they avoid charging for every little thing and consistently provide a high quality of support. As one Manager interviewed by KLAS Research in May 2025 shared, “The support from Moxe is outstanding. The [team] is very responsive, transparent, and willing to help and support us if we have needs or questions.”

The Best in KLAS designation is more than an award; it is a reflection of the deep-seated trust partners place in the Moxe framework. Moxe ensures that the right data is shared with only approved requestors for authorized use cases. Every time.

Visit klasresearch.com to learn more about Moxe’s award as the 2026 Best in KLAS winner.

About Moxe

Moxe connects the healthcare ecosystem with high quality, meaningful clinical data across our trusted network. As the leading EHR-neutral interoperability solution, Moxe improves collaboration by simplifying the way providers securely share data and enabling payers to acquire the data they need, when and how they need it. Moxe’s API-first approach streamlines the acquisition, management, and delivery of precise data to support payment and operations use cases. www.moxehealth.com

About KLAS Research

KLAS is a research and insights firm on a global mission to improve healthcare. Working with thousands of healthcare professionals and clinicians, KLAS gathers data and insights on software and services to deliver timely reports and performance data that represent provider and payer voices and act as catalysts for improving vendor performance. The KLAS research team publishes reports covering the most pressing questions facing healthcare technology today, including emerging technology insights, that provide early insights on the future of healthcare technology solutions. KLAS also fosters measurement and collaboration between healthcare providers and payers and best practice adoption. Learn more at klasresearch.com.

Contacts

Media contact:
Meghan Brennan, Director of Marketing
mbrennan@moxehealth.com
401-368-1211

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

Verimatrix: Sale of Extended Threat Defense Assets (Mobile Application Protection) to Guardsquare

Verimatrix: Sale of Extended Threat Defense Assets (Mobile Application Protection) to Guardsquare

Completion of the sale of XTD assets (code and mobile application protection), including a portfolio of patents and a team of experts. The Group is refocusing on
Share
AI Journal2026/02/06 00:49
IP Hits $11.75, HYPE Climbs to $55, BlockDAG Surpasses Both with $407M Presale Surge!

IP Hits $11.75, HYPE Climbs to $55, BlockDAG Surpasses Both with $407M Presale Surge!

The post IP Hits $11.75, HYPE Climbs to $55, BlockDAG Surpasses Both with $407M Presale Surge! appeared on BitcoinEthereumNews.com. Crypto News 17 September 2025 | 18:00 Discover why BlockDAG’s upcoming Awakening Testnet launch makes it the best crypto to buy today as Story (IP) price jumps to $11.75 and Hyperliquid hits new highs. Recent crypto market numbers show strength but also some limits. The Story (IP) price jump has been sharp, fueled by big buybacks and speculation, yet critics point out that revenue still lags far behind its valuation. The Hyperliquid (HYPE) price looks solid around the mid-$50s after a new all-time high, but questions remain about sustainability once the hype around USDH proposals cools down. So the obvious question is: why chase coins that are either stretched thin or at risk of retracing when you could back a network that’s already proving itself on the ground? That’s where BlockDAG comes in. While other chains are stuck dealing with validator congestion or outages, BlockDAG’s upcoming Awakening Testnet will be stress-testing its EVM-compatible smart chain with real miners before listing. For anyone looking for the best crypto coin to buy, the choice between waiting on fixes or joining live progress feels like an easy one. BlockDAG: Smart Chain Running Before Launch Ethereum continues to wrestle with gas congestion, and Solana is still known for network freezes, yet BlockDAG is already showing a different picture. Its upcoming Awakening Testnet, set to launch on September 25, isn’t just a demo; it’s a live rollout where the chain’s base protocols are being stress-tested with miners connected globally. EVM compatibility is active, account abstraction is built in, and tools like updated vesting contracts and Stratum integration are already functional. Instead of waiting for fixes like other networks, BlockDAG is proving its infrastructure in real time. What makes this even more important is that the technology is operational before the coin even hits exchanges. That…
Share
BitcoinEthereumNews2025/09/18 00:32
BlackRock boosts AI and US equity exposure in $185 billion models

BlackRock boosts AI and US equity exposure in $185 billion models

The post BlackRock boosts AI and US equity exposure in $185 billion models appeared on BitcoinEthereumNews.com. BlackRock is steering $185 billion worth of model portfolios deeper into US stocks and artificial intelligence. The decision came this week as the asset manager adjusted its entire model suite, increasing its equity allocation and dumping exposure to international developed markets. The firm now sits 2% overweight on stocks, after money moved between several of its biggest exchange-traded funds. This wasn’t a slow shuffle. Billions flowed across multiple ETFs on Tuesday as BlackRock executed the realignment. The iShares S&P 100 ETF (OEF) alone brought in $3.4 billion, the largest single-day haul in its history. The iShares Core S&P 500 ETF (IVV) collected $2.3 billion, while the iShares US Equity Factor Rotation Active ETF (DYNF) added nearly $2 billion. The rebalancing triggered swift inflows and outflows that realigned investor exposure on the back of performance data and macroeconomic outlooks. BlackRock raises equities on strong US earnings The model updates come as BlackRock backs the rally in American stocks, fueled by strong earnings and optimism around rate cuts. In an investment letter obtained by Bloomberg, the firm said US companies have delivered 11% earnings growth since the third quarter of 2024. Meanwhile, earnings across other developed markets barely touched 2%. That gap helped push the decision to drop international holdings in favor of American ones. Michael Gates, lead portfolio manager for BlackRock’s Target Allocation ETF model portfolio suite, said the US market is the only one showing consistency in sales growth, profit delivery, and revisions in analyst forecasts. “The US equity market continues to stand alone in terms of earnings delivery, sales growth and sustainable trends in analyst estimates and revisions,” Michael wrote. He added that non-US developed markets lagged far behind, especially when it came to sales. This week’s changes reflect that position. The move was made ahead of the Federal…
Share
BitcoinEthereumNews2025/09/18 01:44